Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study.

PubWeight™: 3.69‹?› | Rank: Top 1%

🔗 View Article (PMC 3220620)

Published in BMJ on November 18, 2011

Authors

Mariana Lazo1, Ruben Hernaez, Susanne Bonekamp, Ihab R Kamel, Frederick L Brancati, Eliseo Guallar, Jeanne M Clark

Author Affiliations

1: Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. mlazo@jhsph.edu

Articles citing this

The global burden of liver disease: the major impact of China. Hepatology (2014) 4.23

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 2.92

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol (2012) 2.25

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology (2013) 2.03

Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol (2013) 1.77

Association between Helicobacter pylori and mortality in the NHANES III study. Gut (2013) 1.74

Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study. Hepatology (2015) 1.67

Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2012) 1.20

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol (2014) 1.20

Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr (2014) 1.20

Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study. Atherosclerosis (2014) 1.16

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med (2014) 1.14

Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. World J Gastroenterol (2014) 1.10

Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? J Obes (2012) 1.08

Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol (2012) 1.07

Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr (2014) 1.05

Cholecystectomy Causes Ultrasound Evidence of Increased Hepatic Steatosis. World J Surg (2016) 1.02

Differences between adiposity indicators for predicting all-cause mortality in a representative sample of United States non-elderly adults. PLoS One (2012) 1.00

Pathogenesis of liver cirrhosis. World J Gastroenterol (2014) 0.99

Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study. Am J Gastroenterol (2016) 0.99

What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J Gastroenterol (2013) 0.99

The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. Clin Liver Dis (2012) 0.97

Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Diabet Med (2013) 0.94

Racial differences in nonalcoholic fatty liver disease in the U.S. population. Obesity (Silver Spring) (2013) 0.93

Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. J Diabetes Complications (2013) 0.93

Cadmium exposure and liver disease among US adults. J Gastrointest Surg (2013) 0.92

Defining hepatic dysfunction parameters in two models of fatty liver disease in zebrafish larvae. Zebrafish (2013) 0.91

Noninvasive fatty liver markers predict liver disease mortality in the U.S. population. Hepatology (2016) 0.91

Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol (2014) 0.89

Comorbidities and Metabolic Derangement of NAFLD. J Lifestyle Med (2015) 0.89

The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the Insulin Resistance Atherosclerosis Study. Diabetologia (2013) 0.89

Nonalcoholic fatty liver disease (NAFLD): is it really a serious condition? Hepatology (2012) 0.88

Non-alcoholic fatty liver disease in 2015. World J Hepatol (2015) 0.88

Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease. PLoS One (2015) 0.87

Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States. J Gastroenterol Hepatol (2014) 0.86

Mortality caused by chronic liver disease among American Indians and Alaska Natives in the United States, 1999-2009. Am J Public Health (2014) 0.85

Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA. BMC Med (2014) 0.84

Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study. BMJ Open (2014) 0.84

Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World J Hepatol (2015) 0.83

Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease. Int J Hepatol (2012) 0.83

Greater Skeletal Muscle Fat Infiltration Is Associated With Higher All-Cause and Cardiovascular Mortality in Older Men. J Gerontol A Biol Sci Med Sci (2015) 0.83

Non-alcoholic fatty liver disease - the heart of the matter. World J Hepatol (2015) 0.82

Prognosis and staging of non-alcoholic fatty liver disease. BMJ (2011) 0.82

Factors associated with significant liver fibrosis assessed using transient elastography in general population. World J Gastroenterol (2015) 0.82

Perceptions of non-alcoholic fatty liver disease - an Asian community-based study. Gastroenterol Rep (Oxf) (2015) 0.81

Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery. Clin Gastroenterol Hepatol (2015) 0.81

Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease. J Nutr Biochem (2015) 0.81

Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease. Dig Dis Sci (2016) 0.80

Natural History of Nonalcoholic Fatty Liver Disease. Dig Dis Sci (2016) 0.80

Gender differences in the association between serum γ-glutamyltransferase and blood pressure change: a prospective community-based cohort study. J Korean Med Sci (2014) 0.80

γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study. Diabetologia (2015) 0.79

Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open (2014) 0.79

Osthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistance. World J Gastroenterol (2014) 0.79

Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease. World J Transplant (2014) 0.78

Knowing What's Out There: Awareness of Non-Alcoholic Fatty Liver Disease. Front Med (Lausanne) (2014) 0.78

Cardiovascular disease in patients with non-alcoholic fatty liver disease. Ann Gastroenterol (2012) 0.78

Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature review. J Tehran Heart Cent (2014) 0.78

Liver Perilipin 5 Expression Worsens Hepatosteatosis But Not Insulin Resistance in High Fat-Fed Mice. Mol Endocrinol (2015) 0.77

Nonalcoholic fatty liver disease is associated with cognitive function in adults. Neurology (2016) 0.77

Nonalcoholic fatty liver disease - A multisystem disease? World J Gastroenterol (2016) 0.77

Association between non-alcoholic fatty liver disease and ischemic stroke. Iran J Neurol (2014) 0.76

Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality. World J Gastroenterol (2015) 0.76

Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis. Sci Rep (2016) 0.76

Are patients with alcohol-related fatty liver at increased risk of coronary heart disease? Clin Mol Hepatol (2014) 0.75

Rationale, design, and methods for Canadian alliance for healthy hearts and minds cohort study (CAHHM) - a Pan Canadian cohort study. BMC Public Health (2016) 0.75

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Curr Hepatol Rep (2016) 0.75

Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis. Int J Clin Exp Med (2015) 0.75

Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr (2017) 0.75

Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients. Can J Gastroenterol Hepatol (2016) 0.75

The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population. J Clin Gastroenterol (2016) 0.75

Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population. Sci Rep (2016) 0.75

Genetic analysis of nonalcoholic fatty liver disease within a Caribbean-Hispanic population. Mol Genet Genomic Med (2015) 0.75

Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists. BMC Res Notes (2016) 0.75

Mortality and non-alcoholic fatty liver disease: type of study cohort matters! Natl Med J India (2012) 0.75

Vitamin D Is Associated with Severity and Mortality of Non-alcoholic Fatty Liver Disease: A US Population-based Study. J Clin Transl Hepatol (2017) 0.75

Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation. PLoS One (2017) 0.75

The relationship between sugar-sweetened beverages and liver enzymes among healthy premenopausal women: a prospective cohort study. Eur J Nutr (2015) 0.75

Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation. J Nutr (2017) 0.75

The ABCC6 Transporter: A New Player in Biomineralization. Int J Mol Sci (2017) 0.75

Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease. J Clin Gastroenterol (2017) 0.75

Nonalcoholic fatty liver disease and mortality among cancer survivors. Cancer Epidemiol (2017) 0.75

Bee's honey attenuates non-alcoholic steatohepatitis-induced hepatic injury through the regulation of thioredoxin-interacting protein-NLRP3 inflammasome pathway. Eur J Nutr (2015) 0.75

Articles cited by this

The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology (2005) 15.74

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology (1999) 11.76

Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology (2006) 10.05

Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol (1997) 9.25

The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol (2003) 8.23

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med (2010) 7.12

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology (2002) 6.62

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology (2005) 4.86

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology (2007) 4.83

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology (2010) 4.83

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology (2003) 4.69

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol (2005) 4.65

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology (1999) 3.99

The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology (1995) 3.73

The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis (2008) 3.69

Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med (1988) 3.66

Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA (2003) 3.51

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes (2005) 3.36

Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol (2008) 3.23

The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol (2003) 3.04

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology (2011) 3.00

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol (2008) 2.87

A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med (1999) 2.86

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology (2010) 2.86

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol (2007) 2.71

Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology (2008) 2.63

Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut (2004) 2.15

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care (2007) 2.09

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol (2008) 1.71

Final results of a long-term, clinical follow-up in fatty liver patients. Scand J Gastroenterol (2009) 1.65

Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr Opin Lipidol (2008) 1.62

Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study. Hepatogastroenterology (2003) 1.24

Articles by these authors

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med (2004) 17.79

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med (2004) 10.35

The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol (2003) 8.23

Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med (2011) 7.81

Readability standards for informed-consent forms as compared with actual readability. N Engl J Med (2003) 7.58

Body-mass index and mortality in Korean men and women. N Engl J Med (2006) 7.50

A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med (2009) 7.45

Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med (2007) 6.09

A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med (2013) 5.52

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care (2011) 5.50

Enough is enough: Stop wasting money on vitamin and mineral supplements. Ann Intern Med (2013) 5.28

Brief communication: clinical implications of short-term variability in liver function test results. Ann Intern Med (2008) 5.27

Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA (2012) 5.15

Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA (2008) 4.48

Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med (2007) 4.43

Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA (2003) 4.33

Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med (2013) 4.25

Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med (2010) 4.24

Nonalcoholic fatty liver disease. Gastroenterology (2002) 4.15

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92

Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA (2008) 3.83

Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med (2015) 3.79

The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis (2008) 3.69

Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring) (2011) 3.62

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch Intern Med (2008) 3.54

Rapid response systems: a systematic review. Crit Care Med (2007) 3.51

Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation (2006) 3.47

Neighborhood characteristics and availability of healthy foods in Baltimore. Am J Prev Med (2008) 3.46

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA (2011) 3.37

Trends in the prevalence of type 2 diabetes in Asians versus whites: results from the United States National Health Interview Survey, 1997-2008. Diabetes Care (2011) 3.36

Random-effects meta-analysis of inconsistent effects: a time for change. Ann Intern Med (2014) 3.30

Lead exposure and cardiovascular disease--a systematic review. Environ Health Perspect (2006) 3.11

Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10

Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educ (2003) 3.05

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. J Clin Oncol (2011) 3.03

Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol (2002) 2.96

Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care (2007) 2.92

Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol (2005) 2.90

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology (2010) 2.86

The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med (2009) 2.84

Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation (2004) 2.83

A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med (2011) 2.81

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69

Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med (2005) 2.67

Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death. Circ Cardiovasc Imaging (2012) 2.62

Cadmium exposure and incident cardiovascular disease. Epidemiology (2013) 2.55

Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol (2013) 2.50

Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care (2009) 2.49

Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol (2010) 2.46

Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect (2006) 2.44

Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2006) 2.40

Impact of bariatric surgery on health care costs of obese persons: a 6-year follow-up of surgical and comparison cohorts using health plan data. JAMA Surg (2013) 2.39

Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third National Health and Nutrition Examination Survey and the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2011) 2.38

Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care (2003) 2.38

Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial. J Sex Med (2009) 2.30

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J (2011) 2.29

A systematic review of interactive computer-assisted technology in diabetes care. Interactive information technology in diabetes care. J Gen Intern Med (2005) 2.28

The burden and treatment of diabetes in elderly individuals in the u.s. Diabetes Care (2006) 2.19

Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med (2011) 2.19

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol (2011) 2.15

Quality of life after acute respiratory distress syndrome: a meta-analysis. Intensive Care Med (2006) 2.13

Randomized controlled trial of the effects of nurse case manager and community health worker interventions on risk factors for diabetes-related complications in urban African Americans. Prev Med (2003) 2.12

Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol (2009) 2.06

Barriers to and facilitators of postpartum follow-up care in women with recent gestational diabetes mellitus: a qualitative study. J Womens Health (Larchmt) (2011) 2.05

Associations of blood lead with estimated glomerular filtration rate using MDRD, CKD-EPI and serum cystatin C-based equations. Nephrol Dial Transplant (2011) 2.04

Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care (2004) 2.03

Influence of serum selenium concentrations on hypertension: the Lipid Analytic Cologne cross-sectional study. J Hypertens (2012) 2.00

Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med (2003) 1.98

Efficacy and safety of statin monotherapy in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci (2007) 1.97

Serum selenium and diabetes in U.S. adults. Diabetes Care (2007) 1.96

The effectiveness of a community/academic health center partnership in decreasing the level of blood pressure in an urban African-American population. Ethn Dis (2003) 1.94

Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet (2015) 1.94

Independent but coordinated trials: insights from the practice-based Opportunities for Weight Reduction Trials Collaborative Research Group. Clin Trials (2010) 1.93

Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006. Diabetes Care (2010) 1.92

Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Am J Epidemiol (2006) 1.91

Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care (2004) 1.90

Hepatitis C virus infection and incident type 2 diabetes. Hepatology (2003) 1.89

The impact of obesity on breast surgery complications. Plast Reconstr Surg (2011) 1.88

Impact of energy intake, physical activity, and population-wide weight loss on cardiovascular disease and diabetes mortality in Cuba, 1980-2005. Am J Epidemiol (2007) 1.87

Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology (2010) 1.86

Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am J Respir Crit Care Med (2008) 1.82

Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med (2008) 1.82

Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation (2004) 1.81

Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. PLoS Genet (2009) 1.81

Performance of A1C for the classification and prediction of diabetes. Diabetes Care (2010) 1.80

Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2012) 1.79